ProfessionalUnited States, National
Hope Neuron
A many-section, trust-and-credibility-driven investor relations site for a biotech developing a non-drug ALS therapy — proof Websprint isn't home-services-only.
Visit the live site →
Hope Neuron is developing SELtx™, a non-drug immune-reset therapy targeting ALS and neurodegenerative disease, under the mission “On a Mission to Reverse ALS.”
What we built
The most structurally complex of our featured builds: a multi-section site spanning Science, Preclinical, Pipeline, Team, Insights, Media and Invest, built for a high-stakes audience of investors and patients rather than local searchers.
Why it works
- A trust-and-credibility-first structure for an audience that’s evaluating science and risk, not comparing quotes.
- Proof the same foundation scales from a local service business to an investor-relations site with an entirely different sales cycle.
- Clear information architecture across seven-plus distinct sections without the site feeling like a maze.
Get started
Want a build like this one?
Tell us about your business — we'll show you how the same approach fits.